Herceptin breast cancer drug molecule

Herceptin breast cancer drug molecule

A617/0260 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.2MB

Downloadable file size: 1.1MB

Price image Pricing

Please login to use the price calculator


Caption: Herceptin breast cancer drug, molecular model. Herceptin (Trastuzumab) is a monoclonal antibody that binds to the HER2 receptor (human epidermal growth factor receptor 2) on breast cancer cells, causing them to die during their reproductive cycle. Around a fifth of breast cancers are made up of cells that over-express this receptor, making them viable for Herceptin treatment. In this model the molecule's shape (secondary structure) is seen, comprising alpha helices (coils), beta sheets (arrows) and linking regions (lines).

Release details: Model release not required. Property release not required.

Keywords: alpha helix, artwork, beta sheet, biochemical, biochemistry, biological, biology, breast cancer, cancer drug, cancer treatment, chemical, chemistry, chemotherapy, compound, compounds, drug, helices, her2, herceptin, human epidermal growth factor, illustration, immunology, medical, medicine, molecular, molecular model, molecule, molecules, monoclonal antibody, oncology, person, pharmacological, pharmacology, protein, proteins, receptor 2, secondary structure, sheets, therapy, trastuzumab, treatment, tumour

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.